Results 121 to 130 of about 58,249 (234)

S1‐Leitlinie Infizierte Zehenzwischenraum‐Intertrigo (sogenannter „gramnegativer Fußinfekt“)

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 6, Page 832-845, June 2026.
Zusammenfassung Die infizierte Zehenzwischenraum‐Intertrigo bezeichnet eine exsudative, mazerierende oberflächliche Mischinfektion der Zehenzwischenräume, bei der gramnegative Bakterien (vor allem Pseudomonas aeruginosa, Enterobacterales) hervorstechen, aber regelmäßig auch grampositive Erreger (Staphylococcus [S.] aureus, koagulasenegative ...
Christoph Zeyen, Dietrich Abeck, Karsten Becker, Joachim Dissemond, Birgit Kahle, Hans Peter Lorenzen, Bettina Löffler, Andreas Maier‐Hasselmann, Till Mittank‐Weidner, Alexander Nast, Cord Sunderkötter   +10 more
wiley   +1 more source

S1 Guideline on Infected Interdigital Intertrigo (also called Gram‐Negative Toe Web Infection)

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 6, Page 832-843, June 2026.
Summary Infected interdigital intertrigo is an exudative, macerating, mixed infection of the toe webs in which gram‐negative bacteria (Pseudomonas aeruginosa and Enterobacterales) seem prevalent, but in which gram‐positive pathogens (Staphylococcus [S.] aureus, streptococci, enterococci) and fungi (dermatophytes, yeasts) also occur.
Christoph Zeyen, Dietrich Abeck, Karsten Becker, Joachim Dissemond, Birgit Kahle, Hans Peter Lorenzen, Bettina Löffler, Andreas Maier‐Hasselmann, Till Mittank‐Weidner, Alexander Nast, Cord Sunderkötter   +10 more
wiley   +1 more source

Adequacy of the Dosing and Infusion Time of Ceftazidime/Avibactam for the Treatment of Gram-Negative Bacterial Infections: A PK/PD Simulation Study

Infection and Drug Resistance
Yun Han,1,* Jianping Zhu,1,* Jieqiong Liu,2 Ying Zheng,2 Gang Liang,1 Yi Yang,1 Lingyan Yu,3 Zhenwei Yu,1 Gang Han1 1Research Center for Clinical Pharmacy, Sir Run Run Shaw Hospital, School of Medicine, College of Pharmaceutical Sciences ...
Han Y, Zhu J, Liu J, Zheng Y, Liang G, Yang Y, Yu L, Yu Z, Han G   +8 more
doaj  

Ceftazidime and cefotaxime--the clinician's choice.

, 1989
A review of two third-generation cephalosporins, ceftazidime and cefotaxime, is presented. Ceftazidime, often used as a single agent, has shown greater activity than cefotaxime against Pseudomonas aeruginosa and other Pseudomonas species ...
Puthucheary, S.D., Goldsworthy, P.J.
core  

Resistance to oxyimino-cephalosporins conferred by an alternative mechanism of hydrolysis by the Acinetobacter-derived cephalosporinase-33 (ADC-33), a class C β-lactamase present in carbapenem-resistant Acinetobacter baumannii (CRAb)

mBio
Antimicrobial resistance in Acinetobacter baumannii is partly mediated by chromosomal class C β-lactamases, the Acinetobacter-derived cephalosporinases (ADCs).
Rachel A. Powers, Bradley J. Wallar, Hannah R. Jarvis, Zoe X. Ziegler, Cynthia M. June, Christopher R. Bethel, Andrea M. Hujer, Magdalena A. Taracila, Susan D. Rudin, Kristine M. Hujer, Fabio Prati, Emilia Caselli, Robert A. Bonomo   +12 more
doaj   +1 more source

Ceftazidime [PDF]

Reactions Weekly, 2020
openaire   +2 more sources

Ceftazidime in the treatment of febrile immunosuppressed children

, 1983
We carried out a pilot study using ceftazidime alone in the treatment of febrile, neutropenic children. A total of 16 episodes were treated before the study was re-evaluated and tobramycin was added.
Williamson, P J, Mott, M G, Speller, D C, Pedler, S J, Darbyshire, P J, Oakhill, A   +5 more
core  

Comparison of imipenem and ceftazidime as therapy for severe melioidosis.

, 1999
An open, prospective, randomized, comparative treatment trial was conducted to compare the therapeutic efficacy of high-dose intravenous imipenem and ceftazidime for acute severe melioidosis.
Smith, MD, Simpson, AJ, Angus, Brian, Rajanuwong, A, Suputtamongkol, Y, Wuthiekanun, V, Howe, PA, Walsh, AL, Chaowagul, W, Angus, BJ, White, NJ, White, Nicholas   +11 more
core   +1 more source

Ceftazidime: A significant advance in the treatment of cystic fibrosis

, 1983
Intravenous ceftazidime (140 mg/kg/day for 14 days) was used in 28 consecutive admissions for severe respiratory infections in children and young adults with cystic fibrosis.
Connor, P. J., Phillips, B. M., David, T. J.   +2 more
core   +2 more sources

Therapeutic drug monitoring of ceftazidime/avibactam: why one leg is not enough to run

Background: Therapeutic drug monitoring (TDM) is becoming an increasingly recommended approach for assessing optimal pharmacokinetic/pharmacodynamic (PK/PD) target attainment of ceftazidime/avibactam.
Gatti, Milo, Viale, Pierluigi, Pea, Federico   +2 more
core   +1 more source